Network Pharmacology Analysis of Hewei Jiangni Granule for Gastroesophageal Reflux Disease and Experimental Verification of Its Anti-Neurogenic Inflammation Mechanism
Yuan Cheng,1,2,* Fushun Kou,1,2,* Xiaosi Zhang,1,2 Yi Dai,3 Lei Shi,2 Chune Xie,2 Xiaohong Li,2 Junxiang Li2 1Second Clinical Medical College, Beijing University of Chinese Medicine, Beijing, People’s Republic of China; 2Department of Gastroenterology, Dongfang Hospital, Beijing Univ...
Main Authors: | Cheng Y, Kou F, Zhang X, Dai Y, Shi L, Xie C, Li X, Li J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-05-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/network-pharmacology-analysis-of-hewei-jiangni-granule-for-gastroesoph-peer-reviewed-fulltext-article-DDDT |
Similar Items
-
Hewei Jiangni granule alleviates visceral hypersensitivity in a rat model of non-erosive reflux disease via transient receptor potential channel signaling
by: Jiali Liu, et al.
Published: (2020-04-01) -
Qingre Jiangni formula improves esophageal epithelial barrier function in gastroesophageal reflux rats through male hormones and the p38/MAPK pathway
by: Zhengyan Jiang, et al.
Published: (2024-01-01) -
Correlation between cough and gastroesophageal reflux in children
by: A. V. Burlutskaya, et al.
Published: (2022-09-01) -
GASTROESOPHAGEAL REFLUX DISEASE’S IMPACT ON CHILDREN’S HEALTH
by: Ana Maria Laura Buga, et al.
Published: (2023-03-01) -
Knowledge of pediatrician on gastroesophageal reflux/gastroesophageal reflux disease in children: a preliminary study
by: Edward Surjono, et al.
Published: (2016-10-01)